Clincosm LogoSign in Get a demo

myelodysplastic syndromes

Showing 76 - 100 of 840
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial (LP-108, Azacitidine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • (no location specified)
Nov 29, 2022

MDS Trial in Tampa (Canakinumab Injection, Darbepoetin Alfa)

Recruiting
  • Myelodysplastic Syndromes
  • Canakinumab Injection
  • Darbepoetin Alfa
  • Tampa, Florida
    Moffitt Cancer Center
Nov 21, 2022

Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, MDS Trial in Canada, United States (ASTX727)

Enrolling by invitation
  • Acute Myeloid Leukemia
  • +2 more
  • Fountain Valley, California
  • +28 more
Nov 18, 2022

MDS, Chronic Myelocytic Leukemia, Acute Myeloid Leukemia Trial in United States (Azacitidine, ASTX030 (cedazuridine +

Recruiting
  • Myelodysplastic Syndromes
  • +3 more
  • Hackensack, New Jersey
  • +6 more
Nov 18, 2022

MDS Over Time - Comparison of Treated vs Untreated Patients

Completed
  • Myelodysplastic Syndromes
    • Vienna, Austria
      Hanusch Krankenhaus, 3.Medizinische Abteilung
    Nov 21, 2022

    Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Houston (DSP107, Azacitidine, Venetoclax)

    Recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • DSP107
    • +2 more
    • Houston, Texas
      The University of Texas MD Anderson Cancer Center, Department of
    Nov 13, 2022

    Multiple Myeloma, Acute Myeloid Leukemia, Non Hodgkin Lymphoma Trial in United States (PRT1419)

    Completed
    • Multiple Myeloma
    • +3 more
    • Denver, Colorado
    • +4 more
    Nov 14, 2022

    Hematopoietic Stem Cell Transplantation, Acute GVHD, Acute Myeloid Leukemia Trial in United States (CD24Fc, Placebo,

    Terminated
    Has Results
    • Hematopoietic Stem Cell Transplantation
    • +4 more
    • Duarte, California
    • +3 more
    Oct 18, 2022

    Anemia, MDS Trial in Germany (Canakinumab Injection)

    Recruiting
    • Anemia
    • Myelodysplastic Syndromes
    • Canakinumab Injection
    • Berlin, Germany
    • +5 more
    Nov 8, 2022

    Solid Tumor, Adult, Acute Myeloid Leukemia, MDS Trial in India (AUR103)

    Recruiting
    • Solid Tumor, Adult
    • +3 more
    • Surat, Gujarat, India
    • +5 more
    Oct 31, 2022

    MDS, MDS, Thrombocytopenia Trial (Placebo, Romiplostim)

    Completed
    Has Results
    • MDS
    • +2 more
    • Placebo
    • Romiplostim
    • (no location specified)
    Nov 4, 2022

    MDS, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Ann Arbor (Pembrolizumab)

    Terminated
    • Myelodysplastic Syndromes
    • +2 more
    • Ann Arbor, Michigan
      University of Michigan Cancer Center
    Nov 1, 2022

    MDS, Myeloproliferative Chronic Myelomonocytic Leukemia Trial in Houston (Cladribine, Cytarabine, Venetoclax)

    Recruiting
    • Myelodysplastic Syndromes
    • Myeloproliferative Chronic Myelomonocytic Leukemia
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 31, 2022

    Fanconi Anemia, Severe Aplastic Anemia, MDS Trial in Minneapolis (Total Body Irradiation (TBI) (Plan 1), Cyclophosphamide (CY)

    Recruiting
    • Fanconi Anemia
    • +2 more
    • Total Body Irradiation (TBI) (Plan 1)
    • +8 more
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    Nov 2, 2022

    Acute Myeloid Leukemia, Myeloid and Monocytic Leukemia, MDS Trial in Minneapolis, Saint Louis, Rochester (Decitabine,

    Completed
    • Acute Myeloid Leukemia
    • +2 more
    • Minneapolis, Minnesota
    • +2 more
    Nov 2, 2022

    MDS, Myelodysplastic Anemia, Myelodysplastic Syndrome With Isolated Del(5Q) Trial (description of MDS pzatient cohort)

    Recruiting
    • Myelodysplastic Syndromes
    • +5 more
    • description of MDS pzatient cohort
    • Brest, France
      Chu Brest
    Oct 27, 2022

    Acute Myeloid Leukemia, MDS Trial (Galinpepimut-S)

    Available
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndromes
    • Galinpepimut-S
    • (no location specified)
    Oct 20, 2022

    Anemia, MDS, Chronic Myelomonocytic Leukemia Trial in France, United States (Sotatercept)

    Completed
    Has Results
    • Anemia
    • +5 more
    • Denver, Colorado
    • +19 more
    Oct 20, 2022

    Acute Leukemia in Remission, MDS, Myeloproliferative Syndrome Trial (Fecal Microbiota Transplantation)

    Not yet recruiting
    • Acute Leukemia in Remission
    • +6 more
    • Fecal Microbiota Transplantation
    • Amiens, France
    • +19 more
    Oct 18, 2022

    MDS, Chronic Myelomonocytic Leukemia-2, Secondary Acute Myeloid Leukemia Trial in Nanjing (unrelated umbilical cord blood)

    Recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • unrelated umbilical cord blood
    • Nanjing, Jiangsu, China
      The First Affiliated Hospital with Nanjing Medical University
    Oct 16, 2022

    MDS, Acute Myeloid Leukemia Trial in Australia, France, Germany (Imetelstat)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Acute Myeloid Leukemia
    • Adelaide, Australia
    • +11 more
    Oct 13, 2022

    MDS Trial in Bari, Rozzano (bone marrow withdrawal)

    Recruiting
    • Myelodysplastic Syndromes
    • bone marrow withdrawal
    • Bari, Italy
    • +6 more
    Oct 10, 2022

    Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Buffalo (sargramostim)

    Completed
    • Chronic Myeloproliferative Disorders
    • +5 more
    • sargramostim
    • Buffalo, New York
      Roswell Park Cancer Institute
    Oct 3, 2022

    MDS Trial in United States (Lenalidomide, Luspatercept)

    Recruiting
    • Myelodysplastic Syndromes
    • Miami, Florida
    • +5 more
    Sep 28, 2022

    MDS, Secondary Acute Myeloid Leukemia Trial in Tampa (CD8 Depleted, Non-engrafting,HLA mismatched unrelated donor lymphocytes,

    Recruiting
    • Myelodysplastic Syndromes
    • Secondary Acute Myeloid Leukemia
    • CD8 Depleted, Non-engrafting,HLA mismatched unrelated donor lymphocytes
    • Standard of Care Chemotherapy
    • Tampa, Florida
      Moffitt Cancer Center
    Sep 27, 2022